New medical products often, but by no means always, launch in Europe first. Is the European regulatory environment easier? DOTmed finds out.
Doctors estimate that the first randomized controlled trial of the effect of hospital report cards on patient care might have saved 250 lives, but the findings are open to debate.
The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.
Study on mice suggests Down syndrome's memory decline could be managed like diabetes.
Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.
A cell phone sized gadget could help predict drug side effects while even saying who's your twin -- just by recording brainwaves during sleep. Welcome to iBrain.
Stryker picks up Calif. software company OtisMed, and acquires assets behind Sonopet's ultrasonic aspirators.
A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.
Researchers believe selectively cooling parts of the brain could lower risk for brain damage after an injury or stroke. A fresh take on an old approach: hypothermia.
Men who toiled at factories that exposed them to high levels of bisphenol-A - a plastic softener - were more than four times more likely to experience sexual problems, according to research that adds fuel to fears over BPA exposure.
On Monday, Medtronic shared the latest results of their highly-anticipated Melody transcatheter valve.
"GPS for the Body" could result in more precise guidance of radiation beams to zap tumors.
Drug-eluting stents might break more often than anybody realized, according to a new study in the Nov. 17 issue of the Journal of the American College of Cardiology.
The DOTmed 100 Wisconsin-based, 15-year-old medical parts company takes over a custom-built, 60,000-sq.-ft. facility.
Thanks in part to pressure from the world's governments, health information technology is set to command an 11 percent compound annual growth rate till 2013, according to analysts.
Dr. John Goble, President of Sectra North America for the last 12 years, died on Nov. 7 when his helicopter went down on the way to a Veterans Day event in Southern California.
Almost one in ten radiologists wouldn't tell patients if an interpretation error led to a delayed cancer diagnosis, according to an article published this month in Radiology.
The finding that almost 39 percent of all breast cancers change when they travel to lymph nodes could spur new treatment protocols.
Grants will help researchers design games that show promise in helping kids get fit, but will anybody play them?
Broken long bones that aren't healing could be patched up by shock waves.
Needle-less, pain-free and home drug delivery devices to show growth in the parenteral market, according to analysts.
The American College of Radiology announced it will be among the first to apply for authority to accredit freestanding diagnostic imaging centers as required by new CMS rules.
The announcement of the final rules by CMS, believed to slash imaging reimbursements by 16 percent, could result in mass closings of rural clinics, according to the American College of Radiology.
In the wake of accidental radiation overexposure of hundreds of patients at a Los Angeles hospital, two leading radiologist groups offer guidelines for making sure patients are getting safe scans.
Using a sophisticated computer algorithm, doctors discover the odds of a radiological test leading to a recommendation for another one doubled since 1995.
With good procedural success rates, Melody is on track to becoming the first transcatheter valve cleared by the FDA.
In the battle against breast cancer, PET imaging might be coming into its own with Naviscan's PEM technology.
A potentially rare defect to a biochemical pathway implicated in cystic fibrosis could also lead to diabetes.
Sales up nearly 16 percent from same time last year, although it was still a "hard quarter" because of losses from recent acquisitions.
To the dismay of drinkers, scientists have found evidence that alcohol triggers a mechanism that turns mild-mannered solid tumors into deadly metastases.
Toumaz Technology's tiny monitoring device could have many clinical applications.
DOTmed News talks with the American Cancer Society about why medical groups are opposed to new wellness provisions that could allow employers to offer discounts for healthy workers.
For the first time, scientists create liver cells from adult stem cells, paving the way for a liver cell 'library' that could be used to better predict drug reactions.
BioMedica now has European and some other foreign distribution rights for Onalta, a radiopharmaceutical designed to kill treatment-resistant carcinoids.
New study adds menace to misery for those suffering from migraines with aura.
According to the latest report from NCQA, measures in health care improvement flatlined in 2008.
Radiation oncology hits the road with TomoMobile, a linear accelerator on wheels.
PALLAS, expected to be completed in 2016, will take over from the aging High Flux Reactor, which supplies much of America's nuclear pharmaceutical needs.
Georgia Tech Research Institute is checking whether widespread tracking technology used in hospitals interferes with implantable medical devices.
No correlation yet found between autism and mercury, as research points to mother's antibodies.
By turning off an evolutionarily ancient inhibitory pathway, scientists are able to give animals "near immunity" to record levels of radiation.
It's not how likely you are to have a complication that makes a hospital safe, it's what happens afterward that matters, according to a study in the New England Journal of Medicine.
Tomosynthesis is to mammograms what CT is to X-rays, Siemens says, but U.S. future of technology is uncertain.
FDA reports over 120 of cases of sparking, charred plugs, and fire hazards resulting from cords used in Abbott and Hospira equipment; voluntary recalls issued. The cord-maker Electri-cord, stands by its products.
Screening breakthrough detects PSA levels that other tests read as zero, and could provide men who had their prostates removed but still have cancer with safer, earlier treatments.
3Q earnings see net $200 million in profit thanks to its hold on the ICD, stent markets but it falls short of estimates.
The technique, called Hyper-SAGE, delivers orders-of-magnitude higher sensitivity by reconstructing images from captured xenon gas.
MannKind hopes its insulin inhalant AFRESA avoids the fates of similar Pfizer, Eli Lilly products.
Bill would overturn expected cutbacks but cost taxpayers almost $250 billion over the next 10 years.
Plus, Quest receives second emergency go-ahead from FDA for H1N1 test.
